Alexander JT, Staab EM, Wan W, Franco M, Knitter A, Skandari MR, et al
Clinical trials indicate 15-25% average body weight reduction over 6-12 months, depending on the medication (e.g., more with tirzepatide) and factors like starting weight, lifestyle, and eating habits
Results vary by individual, and no treatment can guarantee specific outcomes
In prepared remarks at the beginning of the meeting on Tuesday, Julie Louise Gerberding, CEO of the Foundation for the NIH, discussed the need for patience and grace along with commitment
With unmatched weight loss results and multi-faceted health benefits, GLP-1 Agonist injections offer the most comprehensive weight management solution